Nutrilyte (American Regent, Inc.)


Welcome to the PulseAid listing for the Nutrilyte drug offered from American Regent, Inc.. This Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Multi-Electrolyte
SUBSTANCE NAME: SODIUM ACETATE; POTASSIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM ACETATE; POTASSIUM ACETATE; CALCIUM ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00


Nutrilyte HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNutrilyte from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 135; 125; 55; 43; 34.5; 22(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-3120_551b56da-71af-4777-8a2b-3bfd7a391f1b
PRODUCT NDC: 0517-3120
APPLICATION NUMBER:

Other SODIUM ACETATE; POTASSIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM ACETATE; POTASSIUM ACETATE; CALCIUM ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Nutrilyte